Serialize, Integrate and Streamline Your Data Effectively with Industry and Government Partners.

Counterfeiting of drugs remains a
pressing issue to the pharmaceutical and life sciences industry. Counterfeits
not only pose a great risk to patient health, but are also damaging to product
quality and brand integrity. The mounting pressure of present and future serialization
and interoperability requirements, as well as, the complexity of supply chains,
requires an in-depth understanding of regulatory frameworks, and effective
coordination and data management across the networks of manufacturers,
distributors, and wholesalers.

To combat these challenges, the 8th
Pharma Anti-Counterfeiting and Brand Protection Summit convenes leaders across
industry and government. The Summit
explores issues ranging from compliance in 2019 and 2023, big data and digital,
integration of systems and processes, the use of alternative technologies, and
coordinating effectively with government and law enforcement.